Introduction
Automated cell counters have revolutionized the cell analysis process, providing accurate and reliable cell counting results in a matter of minutes. The global automated cell counter market has witnessed significant growth in recent years due to the increasing demand for cell-based assays in various fields, including drug discovery, cancer research, and clinical diagnostics. This article provides an overview of the global automated cell counter market, including industry analysis, trends, market size, and forecasts up to 2027.
Market Overview
The global automated cell counter market was valued at USD 579.6 million in 2020 and is expected to reach USD 1,101.9 million by 2027, growing at a CAGR of 9.5% from 2021 to 2027. The market is segmented by product, application, end-user, and region.
By product, the market is divided into benchtop, portable, and handheld automated cell counters. Benchtop automated cell counters dominate the market, accounting for the largest share due to their high throughput and accuracy. Portable and handheld automated cell counters are expected to witness significant growth in the coming years due to their convenience and ease of use.
By application, the market is segmented into research and clinical diagnostics. Research applications dominate the market, accounting for the largest share due to the increasing demand for cell-based assays in drug discovery and cancer research. Clinical diagnostics applications are expected to witness significant growth in the coming years due to the rising prevalence of chronic diseases and the need for accurate and reliable cell counting methods for diagnostic purposes.
By end-user, the market is divided into pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic laboratories. Pharmaceutical and biotechnology companies dominate the market, accounting for the largest share due to their significant investment in research and development activities. Academic and research institutes and hospitals and diagnostic laboratories are expected to witness significant growth in the coming years due to the increasing demand for cell counting methods in research and clinical settings.
By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the market, accounting for the largest share due to the presence of a large number of pharmaceutical and biotechnology companies and academic and research institutes. Asia-Pacific is expected to witness significant growth in the coming years due to the increasing investment in research and development activities and the rising prevalence of chronic diseases in the region.
Industry Analysis
The global automated cell counter market is highly competitive and fragmented, with several key players operating in the market. These players are focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their position in the market. The key players in the market include Beckman Coulter Inc., Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Sysmex Corporation, and Becton, Dickinson and Company.
The market is witnessing several technological advancements, leading to the development of high-throughput and accurate automated cell counters. The integration of artificial intelligence and machine learning algorithms in automated cell counters is providing more accurate and reliable results. The increasing focus on the development of portable and handheld automated cell counters for point-of-care applications is also a significant trend in the market.
Market Size and Forecast
The global automated cell counter market is expected to witness significant growth in the coming years due to the increasing demand for cell-based assays in various fields, including drug discovery, cancer research, and clinical diagnostics. The market is expected to reach USD 1,101.9 million by 2027, growing at a CAGR of 9.5% from 2021 to 2027.
North America dominates the market, accounting for the largest share due to the presence of a large number of pharmaceutical and biotechnology companies and academic and research institutes.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.
